Advertisement
Screener

Glucotrack, Inc. (GCTK) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

1.7 / 5 stars · 18/54 Roast Me

Glucotrack, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

Glucotrack, Inc. (GCTK) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.13% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-03-30

  • Glucotrack, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2025 was 4.13%.
  • Glucotrack, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 4.70%, a 88.00% increase from fiscal 2022.
  • Glucotrack, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 2.50%, a 0.00% change from fiscal 2021.
  • Glucotrack, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2021 was 2.50%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest RateShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 0 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month
2025-12-314.13%
10-K · filed 2026-03-30
2024-07-304.78%
10-K · filed 2026-03-30
2024-06-274.52%
10-K · filed 2025-03-31
2023-12-314.70%
10-K · filed 2025-03-31
2022-12-312.50%
10-K · filed 2024-03-28
2021-12-312.50%
10-K · filed 2023-03-31
2019-12-312.50%
10-K · filed 2021-04-13
2018-12-311.31%
10-K · filed 2020-04-14
2017-12-310.92%
10-K · filed 2019-04-15
2012-12-312.00%
10-K · filed 2013-04-01
2012-09-302.00%
10-Q · filed 2012-11-19
2012-06-302.00%
10-Q/A · filed 2012-09-12
2012-03-122.00%
10-K · filed 2013-04-01
2011-12-312.00%
10-K · filed 2013-04-01
2010-12-312.00%
10-K · filed 2013-04-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
ACCURAY INC (ARAY)United States$0.027B-0.63
PAVmed Inc. (PAVM)United States$0.031B-3.00
InspireMD, Inc. (NSPR)$0.033B
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
CERENOME, INC. (CNSY)United States$0.014B
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47